Page last updated: 2024-12-05
4,4'-biphenyldicarboxylic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4,4'-biphenyldicarboxylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 13084 |
| CHEMBL ID | 3593502 |
| SCHEMBL ID | 69873 |
| MeSH ID | M0529718 |
Synonyms (59)
| Synonym |
|---|
| biphenyl-4,4'-dicarboxylic acid |
| einecs 212-328-3 |
| brn 0523308 |
| nsc 60016 |
| 4,4'-biphenyl dicarboxylic acid |
| (1,1'-biphenyl)-4,4'-dicarboxylic acid |
| [1,4'-dicarboxylic acid |
| nsc-60016 |
| p,p'-diphenic acid |
| 4,4'-dicarboxybiphenyl |
| 4,4'-bibenzoic acid |
| nsc60016 |
| 4,4'-diphenic acid |
| 787-70-2 |
| wln: qvr dr dvq |
| 4,4'-biphenyldicarboxylic acid |
| usaf do-69 |
| biphenyl-4,4'-dicarboxylic acid, 97% |
| OPREA1_519768 |
| STK012281 |
| 4,4'-diphenyldicarboxylic acid |
| b1191 , |
| 4,4'-dibenzoic acid |
| 4-(4-carboxyphenyl)benzoic acid |
| FT-0656177 |
| AKOS000119440 |
| A840924 |
| A839493 |
| 84787-70-2 |
| [1,1'-biphenyl]-4,4'-dicarboxylic acid |
| biphenyl-4,4-dicarboxylic acid |
| 4,4'-bisbenzoic acid |
| 4-09-00-03563 (beilstein handbook reference) |
| FT-0632956 |
| F3096-1199 |
| SCHEMBL69873 |
| biphenyl-4.4'-dicarboxylic acid |
| DTXSID7061140 |
| SY015816 |
| biphenyl-4,4 inverted exclamation mark -dicarboxylic acid |
| mfcd00002554 |
| W-104270 |
| STR04514 |
| PS-7561 |
| AC-23047 |
| CHEMBL3593502 |
| biphenyl-4,4'-dicarboxylic acid, vetec(tm) reagent grade, 97% |
| biphenyl-4,4`-dicarboxylic acid |
| CS-W014653 |
| biphenyl-4,4-dicarboxylicacid |
| fema 3005 |
| YSWG150 |
| Q2662185 |
| CK2208 |
| EN300-17943 |
| 5D8ABY24N2 |
| sandalwood oil from santalum album l. |
| HY-W013937 |
| Z57127884 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1235354 | Antifungal activity against Cochliobolus lunatus strain MUCL 38696 at 100 uM by growth based assay | 2015 | Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15 | Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 40.28
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (40.28) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||